Literature DB >> 1932747

Binding of tissue plasminogen activator to human monocytes and monocytoid cells.

J Felez1, C J Chanquia, E G Levin, L A Miles, E F Plow.   

Abstract

Monocytes and monocytoid cell lines previously have been shown to express receptors for plasminogen and urokinase (u-PA). In the present study, the monocytoid cell lines, U937 and THP-1, are shown to bind tissue plasminogen activator (t-PA) in a specific, saturable, and reversible manner. These cells bound t-PA with low affinity (kd = 0.67 to 0.97 mumol/L) and high capacity (0.71 to 3.3 x 10(6) receptors/cell). Human peripheral blood monocytes bound t-PA with a kd (0.9 mumol/L) similar to that of the monocytoid cells but with a lower capacity (0.17 x 10(6) sites/cell). These binding parameters also were similar to the low-affinity interaction of t-PA with endothelial cells as measured with the cells in suspension (kd = 0.73 mumol/L and 1.1 x 10(6) sites/cell). Lysine analogues and active or diisopropylfluorophosphate-inactivated u-PA inhibited t-PA binding to monocytes, monocytoid cells, and endothelial cells with similar IC50 (concentration producing 50% inhibition) values, suggesting that the same recognition specificity mediates t-PA binding to all of these cell types. The existence of a high-affinity binding site for t-PA on monocytoid cells was also explored in detail. Unlike endothelial cells where plasminogen activator inhibitor-1 has been implicated in mediating a high-affinity interaction of t-PA with the cells, no evidence for a role of this inhibitor in ligand binding to the monocytoid cells was found. Furthermore, using both high and low 125I-t-PA concentrations, competition analyses with lysine analogues or u-PA, or treatment of the cells with carboxypeptidase B, failed to indicate the presence of distinguishable classes of t-PA binding sites. In sum, low-affinity receptors for t-PA are expressed at high density on monocytes and monocytoid cells, identifying a new element in the fibrinolytic arsenal of these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932747

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells.

Authors:  V K Lishko; I S Yermolenko; H Owaynat; T P Ugarova
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

2.  Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.

Authors:  R J Parmer; M Mahata; Y Gong; S K Mahata; Q Jiang; D T O'Connor; X P Xi; L A Miles
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Human Aortic Vascular Smooth Muscle Cells Digest Extracellular Matrix by Elaboration of Plasminogen Activators: Implications for Atherogenesis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.

Authors:  V K Lishko; I S Yermolenko; T P Ugarova
Journal:  J Thromb Haemost       Date:  2009-01-22       Impact factor: 5.824

5.  Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

Authors:  Nicholas M Andronicos; Emily I Chen; Nagyung Baik; Hongdong Bai; Caitlin M Parmer; William B Kiosses; Mark P Kamps; John R Yates; Robert J Parmer; Lindsey A Miles
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

6.  A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.

Authors:  Michael P Motley; Daniel H Madsen; Henrik J Jürgensen; David E Spencer; Roman Szabo; Kenn Holmbeck; Matthew J Flick; Daniel A Lawrence; Francis J Castellino; Roberto Weigert; Thomas H Bugge
Journal:  Blood       Date:  2015-12-08       Impact factor: 22.113

7.  Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

Authors:  Rocco Romagnuolo; Santica M Marcovina; Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2014-01-29       Impact factor: 5.922

8.  Histone H2B as a functionally important plasminogen receptor on macrophages.

Authors:  Riku Das; Tim Burke; Edward F Plow
Journal:  Blood       Date:  2007-08-09       Impact factor: 22.113

Review 9.  The plasminogen receptor, Plg-R(KT), and macrophage function.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Nicholas M Andronicos; Emily I Chen; Caitlin M Parmer; Sophia Khaldoyanidi; Jenna E Diggs; William B Kiosses; Mark P Kamps; John R Yates; Robert J Parmer
Journal:  J Biomed Biotechnol       Date:  2012-10-14

10.  Annexin A2 heterotetramer: structure and function.

Authors:  Alamelu Bharadwaj; Moamen Bydoun; Ryan Holloway; David Waisman
Journal:  Int J Mol Sci       Date:  2013-03-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.